Entero Healthcare Solutions Ltd. - Asset Resilience Ratio
Entero Healthcare Solutions Ltd. (ENTERO) has an Asset Resilience Ratio of 9.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore ENTERO current and non-current assets for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Entero Healthcare Solutions Ltd.'s Asset Resilience Ratio has changed over time. See ENTERO equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Entero Healthcare Solutions Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ENTERO stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs2.73 Billion | 9.58% |
| Total Liquid Assets | Rs2.73 Billion | 9.58% |
Asset Resilience Insights
- Limited Liquidity: Entero Healthcare Solutions Ltd. maintains only 9.58% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Entero Healthcare Solutions Ltd. Industry Peers by Asset Resilience Ratio
Compare Entero Healthcare Solutions Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998 |
Medical Distribution | 0.08% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
Annual Asset Resilience Ratio for Entero Healthcare Solutions Ltd. (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Entero Healthcare Solutions Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-09-30 | 2.13% | Rs575.55 Million ≈ $6.22 Million |
Rs27.03 Billion ≈ $292.27 Million |
-29.54pp |
| 2023-09-30 | 31.67% | Rs7.43 Billion ≈ $80.32 Million |
Rs23.45 Billion ≈ $253.60 Million |
+25.87pp |
| 2022-09-30 | 5.80% | Rs814.82 Million ≈ $8.81 Million |
Rs14.04 Billion ≈ $151.85 Million |
+0.57pp |
| 2021-09-30 | 5.23% | Rs588.90 Million ≈ $6.37 Million |
Rs11.26 Billion ≈ $121.77 Million |
-0.83pp |
| 2020-09-30 | 6.06% | Rs505.10 Million ≈ $5.46 Million |
Rs8.34 Billion ≈ $90.17 Million |
+2.37pp |
| 2019-09-30 | 3.69% | Rs276.62 Million ≈ $2.99 Million |
Rs7.49 Billion ≈ $81.03 Million |
-- |
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more